The Unintended Impact Of DEA's New Registration Policy
Law360, New York (November 18, 2016, 10:46 AM EST) -- A recently announced change in Drug Enforcement Administration policy regarding how it treats untimely renewals of a practitioner's registration could have unintended consequences that will place pharmacies and other providers at risk.
In passing the Comprehensive Drug Abuse Prevention and Control Act of 1970 and the Controlled Substances Import and Export Act (CSIEA) (21 U.S.C. 801-971), as amended (hereinafter, CSA), Congress empowered the DEA (as delegated by the attorney general) to maintain a closed system of distribution to ensure that controlled substances are readily available for the legitimate medical and scientific needs of the United States and to protect the public...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!